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ABSTRACT 
 
 Due to the key role of the human chorionic gonadotropin hormone (hCG) in placental 1 
development, the aim of this study was to characterize the human trophoblastic luteinizing 2 
hormone/chorionic gonadotropin receptor (LH/CG-R) and to investigate its expression using the in 3 
vitro model of human cytotrophoblast differentiation into syncytiotrophoblast. We confirmed by in 4 
situ immunochemistry and in cultured cells, that LH/CG-R is expressed in both villous 5 
cytotrophoblasts and syncytiotrophoblasts. However, LH/CG-R expression decreased during 6 
trophoblast fusion and differentiation, while the expression of hCG and hPL (specific markers of 7 
syncytiotrophoblast formation) increased. A decrease in LH/CG-R mRNA during trophoblast 8 
differentiation was observed by means of semi-quantitative RT-PCR with two sets of primers. A 9 
corresponding decrease (~ 60%) in LH/CG-R protein content was shown by western-blot and 10 
immunoprecipitation experiments. The amount of the mature form of LH/CG-R, detected as a 90-kDa 11 
band specifically binding 
125
I-hCG, was lower in syncytiotrophoblasts than in cytotrophoblasts. This 12 
was confirmed by Scatchard analysis of binding data on cultured cells. Maximum binding at the cell 13 
surface decreased from 3511 to about 929 molecules/seeded cells with a Kd of 0.4 - 0.5 nM. 14 
Moreover, on stimulation by recombinant hCG, the syncytiotrophoblast produced less cyclic AMP 15 
than cytotrophoblasts, indicating that LH/CG-R expression is regulated during human villous 16 
trophoblast differentiation.  17 
 3 
INTRODUCTION 18 
 19 
 Human chorionic gonadotropin (hCG) belongs to a family of glycoprotein hormones, which 20 
includes lutropin (LH), thyrotropin (TSH) and follitropin (FSH). These hormones composed of two 21 
non-covalently linked subunits, alpha () and beta (), are active on bicatenary form. The -subunit is 22 
common to all glycoprotein hormones, whereas the -subunits confer the hormonal specificity (Pierce 23 
and Parsons, 1981). Alpha hCG is encoded by a single gene and ßhCG by six genes, one of which, 24 
CGß5, is predominantly expressed in the placenta (Bo and Boime, 1992). HCG is essential for the 25 
initiation and maintenance of early pregnancy. After implantation, hCG is produced by the placenta 26 
and mainly by the trophoblast (Hoshina et al., 1985; Kliman et al., 1986; Muyan and Boime, 1997, 27 
Handschuh et al., 2006). It is used as a diagnostic marker of pregnancy. 28 
 The human placenta is characterized by extensive invasion of the trophoblast in the maternal 29 
uterus, creating direct trophoblast contact with maternal blood (haemochorial placentation). In early 30 
pregnancy, mononuclear cytotrophoblasts (CT) proliferate and invade the maternal endometrium to 31 
form the anchoring villi. (Aplin, 1991). Cytotrophoblasts also differentiate into a multinucleated 32 
continuous layer known as the syncytiotrophoblast (ST). This cell layer, which covers the chorionic 33 
villi, is bathed by maternal blood in the intervillous spaces from early gestation (Richard, 1961; 34 
Midgley et al., 1963; Boyd and Hamilton, 1970; Benirschke and Kaufmann, 2000). This 35 
syncytiotrophoblast is multifunctional, but its primary functions are exchange of oxygen, nutriments, 36 
removal of waste products and hormone production. The syncytiotrophoblast secretes hCG in large 37 
amounts, directly into the maternal blood bathing the chorionic villi in the intervillous space. 38 
 The mechanisms underlying villous trophoblast differentiation remain largely to be explored. 39 
Syncytiotrophoblast formation in vivo and in vitro arises from villous cytotrophoblast fusion and 40 
differentiation. Several factors modulate villous trophoblast differentiation, including EGF (epidermal 41 
growth factor) and EGF receptor expression (Morrish et al., 1987; Alsat et al., 1993), hypoxia (Alsat et 42 
al., 1996), cAMP-dependent protein kinase (PKA) (Keryer et al., 1998), granulocyte-macrophage 43 
stimulating factor (Garcia-Lloret et al., 1994), transforming growth factor  (TGF) (Morrish et al., 44 
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1991) and oxidative stress due to overexpression of copper zinc superoxide dismutase (Frendo et al., 45 
2000a, 2001). The molecular mechanisms underlying trophoblast membrane fusion are poorly 46 
understood. Proteins involved in cell adhesion (cadherin 11) (Getsios and MacCalman, 2003) and cell-47 
cell communication (connexin 43) (Frendo et al., 2003a) are known to be directly involved. We 48 
recently demonstrated the direct involvement of syncytin I, a human endogenous retroviral envelope 49 
glycoprotein (Frendo et al., 2003b), and the presence of syncytin 2, restricted to some villous 50 
cytotrophoblasts (Malassiné et al, 2006). 51 
 Several studies suggest that hCG stimulates villous trophoblast differentiation by acting on the 52 
LH/CG-R (Shi et al., 1993; Cronier et al., 1994; Yang et al., 2003). This receptor, which has seven 53 
transmembrane domains, belongs to the superfamily of G protein-coupled receptors (Pierce and 54 
Parsons, 1981; Loosfelt et al., 1989; McFarland et al., 1989; Minegishi et al., 1990). The LH/CG 55 
receptor gene has been cloned in pig, mouse, rat and human; in humans it is composed of 11 exons 56 
and 10 introns, and its coding region is over 60 kb long (Segaloff and Ascoli, 1993). HCG binding to 57 
its receptor activates adenylate cyclase, phospholipase C and ion channels, which in turn control 58 
cellular cAMP, inositol phosphates, Ca
2+
 and other secondary messengers (Gudermann et al., 1992; 59 
Hipkin et al., 1992). 60 
 The presence of LH/CG-R in human placenta was first described by Alsat (Alsat and Cedar, 61 
1974) and has since been confirmed by other authors (Reshef et al., 1990; Lei and Rao, 1992). 62 
Inhibition of LH/CG-R expression by specific antisense oligodeoxynucleotides during cytotrophoblast 63 
culture results in time- and concentration-dependent inhibition of cytotrophoblast differentiation, 64 
showing that hCG, via its receptor, is an autocrine and paracrine regulator of human placental 65 
syncytiotrophoblast formation (Yang et al., 2003).  66 
 Most of the studies actually done, have used transfected cells with cDNA from LH/CG-67 
receptor in rat or mouse models. In human, the characterization and the modulation of LH/CG-R 68 
expression during syncytiotrophoblast formation is poorly documented. Here we used the 69 
physiological model of cultured primary human trophoblasts (Kliman et al., 1986; Frendo et al., 70 
2000b), in which isolated mononuclear cytotrophoblasts differentiate and fuse to form a 71 
syncytiotrophoblast, which secretes large amounts of hCG and other pregnancy-related hormones. We 72 
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used various methodological approaches to characterize the hCG/LH receptor, and observed its down-73 
regulation during villous trophoblast differentiation. This was confirmed by in situ immunolocalisation 74 
of the hCG receptor in sections of human placenta. 75 
 76 
 77 
MATERIALS AND METHODS 78 
 79 
Placental tissue collection and trophoblast cell culture 80 
These studies were performed in agreement with our local ethics committee and with written informed 81 
consent of patients. Third trimester placentas were obtained immediately after iterative Caesarian 82 
section from healthy mothers delivered at 35-39 weeks of amenorrhea. First trimester placentas (7-12 83 
weeks of gestation) were collected following legal voluntary interruption of pregnancy from women 84 
who gave their written informed consent. Cytotrophoblasts were isolated as previously described 85 
(Alsat et al., 1993). After sequential trypsin (0.25%)/DNase I digestion followed by Percoll gradient 86 
centrifugation (Frendo et al., 2003a), the cells were further purified by negative selection to obtain a 87 
trophoblast preparation not contaminated by other cells, by using a monoclonal anti-human leukocytic 88 
antigen A, B and C antibodies (W6-32HL, Sera Lab, Crawley Down, UK) according to a published 89 
method (Schmon et al., 1991; Cronier et al., 2002). This antibody reacts with most cell types (e.g. 90 
macrophages, fibroblasts, extravillous trophoblasts) but not with villous cyto- or syncytiotrophoblast. 91 
Cytotrophoblasts were diluted to a final density of 2.7x10
6 
cells in 3 ml of minimum essential medium 92 
(MEM) containing 10% fetal calf serum (FCS). Cells were plated in 60-mm plastic dishes (TPP, 93 
Trasadingen, Switzerland) and incubated at 37°C in 5% CO2. Cytokeratin 7 immunocytochemistry 94 
was performed to confirm the cytotrophoblastic nature of the attached cells: about 95-98% of the cells 95 
were positively stained. 96 
 97 
Hormone assay 98 
The hCG concentration was determined in culture medium after 24 and 72 hours of culture by using 99 
an enzyme-linked fluorescence assay (Vidas System, BioMerieux, Marcy l’Etoile, France) with a 100 
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detection limit of 2 mU/ml. The hPL concentration was determined in 4-fold-concentrated conditioned 101 
medium by using a method (Amerlex IRMA, Amersham Pharmacia Biotech) with a detection limit of 102 
0.5 µg/ml. All reported values are means ± SEM of triplicate determinations. 103 
 104 
Immunohistochemistry 105 
Placental samples were obtained after first-trimester abortion. They were fixed by incubation in 4% 106 
formalin for 4 to 12 h at room temperature and then embedded in paraffin, dewaxed in xylene and 107 
rehydrated in ethanol/water. Immunostaining was performed with a universal streptavidin-peroxidase 108 
immunostaining kit (Peroxidase, Dako LSAB®+Kit, DAKO
©
, Glostrup, Denmark). Non-specific 109 
binding was blocked by incubation for 5 min in a blocking reagent containing 3% H2O2 and then in 110 
3% serum albumin in PBS for 30 min. The sections were incubated with the primary antibody for 30 111 
min at room temperature. The primary antibodies (table 1) were polyclonal anti-human LH/CG-R 112 
(LHR-K15, Santa Cruz Biotechnology Inc, CA, USA, at 2 μg/ml), monoclonal anti-cytokeratin 7 113 
(M7018, DAKO
©
, Glostrup, Denmark, at 1 μg/ml), and polyclonal anti-hCG (A0231 against the beta 114 
subunit of hCG, DAKO
©
, Glostrup, Denmark, at 2 μg/ml). Sections were washed in PBS and 115 
incubated with a biotinylated secondary antibody for 15 min. They were then washed three times in 116 
PBS and incubated with streptavidin conjugated to horseradish peroxidase for 15 min. The sections 117 
were washed in PBS and staining was detected by incubation for 30 seconds with the DAB (3,3’- 118 
diaminobenzidine) chromogen. Controls were performed by incubating the sections with nonspecific 119 
IgG at the same concentration as the primary antibody. Successive pre-adsorptions of LH/CG-R 120 
antibody with trophoblastic cells in culture abrogate LH/CG-R immunodetection. 121 
 122 
Immunocytochemistry 123 
To detect desmoplakin, LH/CG-R, hCG, cytokeratin 7 and hPL, cultured cells were rinsed with PBS, 124 
fixed and permeabilized in methanol at -20°C for 8 min. Alternatively, cultured cells were fixed with 125 
4% paraformaldehyde at 4°C for 20 min. After washing once with PBS, the remaining free aldehyde 126 
groups were blocked by adding 50mM NH,Cl for 10 min. A polyclonal anti-desmoplakin (AHP320, 127 
Serotec, Oxford, UK at 2.5 g/ml), two polyclonal anti-LH/CGR (LHR-K15 and LHR-H50, Santa 128 
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Cruz Biotechnology Inc, CA, USA, at 2 µg/ml), two polyclonal anti-hCG (A0231, DAKO
©
, Glostrup, 129 
Denmark at 2 g/ml and SC-7821, Santa Cruz Biotechnology Inc, CA, USA at 2g/l), a monoclonal 130 
anti-cytokeratin 7 (M7018, DAKO
©
, Glostrup, Denmark, at 2.6 g/ml), or a polyclonal anti-hPL 131 
(A0137, DAKO
©
, Glostrup, Denmark, at 1.6 g/ml) was then applied (table 1), followed by 132 
fluorescein isothiocyanate-labeled goat anti-mouse IgG, or fluorescein isothiocyanate-labeled goat 133 
anti-rabbit IgG (Jackson Immuno Research, Baltimore, USA at 1:150), or Alexa 488-labeled donkey 134 
anti rabbit (Molecular probes Inc, OR, USA at 1:400), or Texas red labeled donkey anti goat (Jackson 135 
Immuno Research, Baltimore, USA at 1:400), or Cy
TM3
 goat anti-rabbit IgG, as previously described 136 
(Frendo et al., 2001). The controls, which consisted of omitting the primary antibody or applying the 137 
non specific IgG of the same isotype, were all negative. 138 
 139 
Immunoblotting 140 
Cell extracts were prepared as previously described (Alsat et al., 1996). Protein (70 g) was 141 
solubilized in RIPA (radioimmunoprecipitation) buffer (50 mM Tris, 150 mM NaCl, 1% Triton X100, 142 
1% deoxycholate, 0.1% SDS, pH: 8), and stained markers were submitted to 7.5% SDS-PAGE and 143 
transferred to nitrocellulose sheets. Membranes were immunoblotted with two polyclonal antibodies 144 
against LH/CG-R, LHR-K15 (goat anti human, Santa Cruz Biotechnology Inc, CA, USA) and LHR-145 
H50 (rabbit anti human, Santa Cruz Biotechnology Inc, CA, USA) at 2 g/ml each, and the specific 146 
band was revealed by chemiluminescence (West Pico Chemiluminescent, Pierce, Rockford, IL, USA) 147 
after incubation with an anti-goat or anti-rabbit peroxidase-coupled antibody (Jackson Immuno 148 
Research, Baltimore, USA). To detect actin, cytokeratin 7, hCG and hPL, we proceeded as described 149 
above, except that proteins were immunoblotted with rabbit polyclonal antibody at 0.7 g/ml for actin 150 
(Sigma-Aldrich, MO, USA), rabbit polyclonal antibody at 0.4 g/ml for hCG and 0.32 g/ml for hPL 151 
(DAKO
©
, Glostrup, Denmark) and mouse monoclonal antibody at 0.5 g/ml for cytokeratin 7 152 
(DAKO
©
, Glostrup, Denmark). Successive pre-adsorptions of LH/CG-R antibody with trophoblastic 153 
cells in culture abrogate LH/CG-R immunodetection in western-blot analysis. 154 
 155 
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 156 
Immunoprecipitation and ligand blotting 157 
Protein G Plus-Agarose (Immuno precipitation Reagent, Santa Cruz Biotechnology Inc, CA, USA) 158 
was pre-mixed with a polyclonal antibody against human LHCG-R (K15, Santa Cruz Biotechnology 159 
Inc, CA, USA), or without antibody. Cells (1.0 x 10
6
/well) were seeded in six-well plates and cultured 160 
as previously described. After 24 hours of culture, cells were washed with PBS and scraped free in 161 
ice-cold RIPA buffer. After sonication, the cellular lysate and debris were separated by centrifugation 162 
at 10000 g for 10 min at 4°C. The supernatant was transferred to the protein G-anti-human LHCG-R 163 
immunocomplex and incubated overnight at 4°C on a rocker platform, followed by four washes in 164 
RIPA buffer. Protein was eluted by heating at 60°C for 10 min in 1X electrophoresis sample buffer 165 
(Bio-Rad laboratories, CA, USA). Aliquots were submitted to 7.5% SDS-PAGE and transferred to 166 
nitrocellulose membranes. Membranes were exposed to antibody as previously described, or the blots 167 
were incubated with 
125
I-hCG at 10
-11
 M (PerkinElmer Life and Analytical Sciences Inc. MA, USA) 168 
for 16 h at 4°C in the absence or presence of excess unlabeled hCG at 10
-6 
M (Organon SA, Puteaux, 169 
France). The blots were washed with PBS containing 0.1% Tween 20, then dried. Bound 
125
I-hCG was 170 
visualized by autoradiography and analyzed by Cyclone (Storage phosphorImaging System, Hewlett 171 
Packard, France). 172 
 173 
RNA extraction 174 
Total RNA was extracted from trophoblastic cells after 24 or 72 hours of culture by using the Trizol 175 
reagent (Invitrogen Life Technologies, CA, USA) and was stored at -80°C or at -20°C in 75% ethanol 176 
until use. The total RNA concentration was determined at 260 nm and RNA integrity was checked in 177 
1% agarose gel. The relative LH/CG-R mRNA levels were determined by semi-quantitative reverse 178 
transcriptase-polymerase chain reaction (RT-PCR). The transcript level was normalized to the actin 179 
mRNA level (endogenous control). 180 
 181 
RT-polymerase chain reaction 182 
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RNA samples were pretreated with DNAse I using the RQ1 RNase-Free DNase kit (Promega Inc, WI, 183 
USA). Briefly, we used 5 units of RQ1 RNase-free DNase per 5 micrograms of RNA, we then added 184 
RQ1 RNase-free 10x reaction buffer and TE buffer. Mixture was incubated at 37°C for 30 min and the 185 
digestion was terminated by the RQ1 DNase stop solution. DNase was then inactivated by heating at 186 
65°C for 10 min. 187 
Complementary DNA was synthesized from 5 µg of total RNA. The reaction mixture had a final 188 
volume of 20 µl and contained 375 mM KCl, 250 mM Tris-HCl (pH 8.3), 15 mM MgCl2, 0.1 M DTT, 189 
40 U of RNAsin®, 200 U of reverse transcriptase Superscript II (Invitrogen Life Technologies, CA, 190 
USA), 10 mM each dNTP and 200 ng of random primers (Invitrogen Life Technologies, CA, USA). 191 
Mixture of total RNA, DTT and random primers was heat at 65°C for 5 min. Annealing was run for 10 192 
min at 25°C and primer extension for 50 min at 42°C. An aliquot of the reaction mixture (5 µl) was 193 
then made up to 45 µl with Taq polymerase buffer containing 1 unit of Taq polymerase Platinium 194 
(Invitrogen Life Technologies, CA, USA). Before heating to 94°C (hot-start), 50 pmol of each specific 195 
primer was added. Amplification was run for 40 cycles for LH/CG-R and for 20 cycles for actin, 196 
consisting of 1 min at 94°C (denaturation), 1 min at 55°C (annealing) and 1 min at 72°C (extension). 197 
Oligonucleotide primers specific for the coding sequence of LH/CG-R (NM_000233) were used (Fig. 198 
3A): P1 (+): 5'-CAAGCTTTCAGAGGACTTAATGAGGTC-3'; P1 (-): 5'-AAAGCACAGCAGTGG 199 
CTGGGGTA-3'; P2 (+): 5'-TCGACTATCACTTGCCTACC-3'; P2 (-): 5'-GGAGAAGACCTTCGTA 200 
ACAT-3'; Actin (NM_001101) (+): 5'-GTGGGGCGCCCCAGGCACCA-3'; Actin (-): 5'-CTCCTTA 201 
ATGTCACGCACGATTTC-3'. Amplified products were analyzed by electrophoresis on 1.8% agarose 202 
gels and visualized by ethidium bromide staining. 203 
 204 
Cloning and DNA sequencing of LH/CG-R from trophoblastic cells 205 
PCR products were eluted from agarose gel by using the Macherey Nagel kit (NucleoSpin Extract II, 206 
MN, Hoerdt, France) and purified DNA fragments were cloned into the pCRII-TOPO vector by using 207 
the TOPO-TA Cloning kit (Invitrogen Life Technologies, CA, USA). Positive clones were selected by 208 
PCR and were sequenced by Genome Express (Meylan, France). Both strands of DNA fragments were 209 
sequenced, using Ml3 reverse and Ml3 forward primers. 210 
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 211 
 212 
Intracellular cAMP determination 213 
Cells (1.0 x 10
6
/well) were seeded in six-well plates and cultured as described above. After 24 h or 72 214 
h, cells were preincubated with 10mM IBMX (3-isobutyl-1methylxanthine) for 1 hour to prevent 215 
cAMP degradation and were stimulated for 20 min with 10
-8 
M hCG (C6322, Sigma-Aldrich, MO, 216 
USA). Cells were frozen on dry ice and cAMP was extracted with ice-cold 65% ethanol. The extracts 217 
were dried and kept at -20°C until use. Cyclic AMP was assayed after acetylation by using a method 218 
(Amersham Biosciences, NJ, USA) based on the competition between unlabelled cAMP and a fixed 219 
quantity of 
125
I-labelled cAMP for binding to a cAMP-specific antibody. Bound antibody was 220 
separated from free fraction by magnetic separation with a second antibody Amerlex
TM
-M preparation 221 
that is bound to magnetizable polymer particles. Separation of the antibody bound fraction is effected 222 
either by magnetic separation of the Amerlex
TM
-M suspension or decantation of the supernatant. The 223 
concentration of unlabelled cAMP in the sample was then determined by interpolation from a standard 224 
curve. 225 
 226 
Binding assay and Scatchard analyses 227 
Trophoblastic cells (1.0 x 10
6
/well) were seeded in six-well plates and cultured as described above. 228 
After 24 h or 72 h of culture the cells were washed five times and cultured in DMEM, 0.1% BSA for 2 229 
hours to dissociate any bound endogenous hCG. The cells were then washed and placed in 1 ml of 230 
DMEM containing 0.1% BSA and 1 mM HEPES, pH 7.3. Cells were incubated for 30 min at room 231 
temperature with 0.5 nM 
125
I-hCG and an increasing concentration of unlabelled hCG (from 10
-12 
M to 232 
10
-8 
M, C6322, Sigma-Aldrich, MO, USA) on a shaker platform at 50 cycles/min. At the end of the 233 
incubation period the cells were washed and scraped free, and bound radioactivity was counted. Each 234 
assay was performed in triplicate. Data were analyzed by using the LIGAND fitting program (version 235 
4.97) (Munson and Rodbard, 1980). For Scatchard analysis, the results showing the number of labeled 236 
molecules associated with the cellular membrane were expressed in a number of molecule associated 237 
per seeded cells. For comparison between CT and ST experiments, nuclei were counted at 24h and 72h 238 
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of culture after staining with DAPI, as previously described in the immunocytochemistry section. We 239 
did not observe difference between the number of nuclei at 24h and 72h of culture (CT are non 240 
proliferative cells and apoptosis or cellular loss account for about 4% (data not shown). 241 
125
I-labeled hCG was prepared using chloramine T as oxidant (Hunter and Greenwood, 1962). In a 242 
final volume of 20 µl, hCG (5 µg, 4.4 µM) was added to 0.5 mCi of Na
125
I (Perkin-Elmer Life and 243 
Analytical Sciences, MA, USA; 17.4 Ci/mg, 11.5 µM) neutralized with 0.1 M Mops and poly(ethylene 244 
glycol) 1000 (1%). The reaction in 25 mM Mops buffer pH 7.2 was started by adding 100 µM 245 
chloramine-T for 3 min at room temperature and was stopped by adding 120 µM sodium bisulfite for 3 246 
min and 2 mM NaI for 1 min. The volume was then adjusted to 0.5 ml with Mops-buffered saline (20 247 
mM Mops, 130 mM NaCl, pH 7.2) containing 1 mg/ml BSA. Iodinated-hCG was desalted on a PD10 248 
Sephadex G25-M column in the same buffer. Specific activity of 
125
I-hCG was 2.1-2.4 Ci/µmole 249 
corresponding to about 1 atom of iodine per molecule hCG. 250 
 251 
Statistical analysis 252 
We used the StatView F-4.5 software package (Abacus Concepts, Inc., CA, USA). Values are reported 253 
as means  SEM. Significant differences (p<0.05) were identified by analysis of variance (ANOVA). 254 
 255 
 256 
RESULTS 257 
 258 
Human villous trophoblast differentiation in vitro 259 
We used the primary cell culture model of villous cytotrophoblasts isolated from term placenta 260 
(Kliman et al., 1986; Alsat et al., 1991). Figure 1 shows purified cytotrophoblasts cultured on plastic 261 
dishes for 24 and 72 hours. Mononuclear cytotrophoblasts fused and formed multinucleated 262 
syncytiotrophoblasts, 72 hours after plating (Kliman et al., 1986). Syncytiotrophoblast formation was 263 
associated with a significant increase in hCG and hPL levels in the culture medium (Fig. 1 I). 264 
Concomitantly, immunostaining for hCG (Fig. 1 A and B) and hPL (Fig. 1 F and H) showed an 265 
increase in intensity during in vitro syncytiotrophoblast formation. HPL, expressed mainly by the 266 
 12 
syncytiotrophoblast (Handwerger, 1991), was detected by immunostaining at 72 h (Fig. 1 D and H) 267 
but not at 24 h (Fig. 1 C and F). Immunostaining of cytokeratin 7, expressed by trophoblastic cells 268 
(Blaschitz et al., 2000), was positive at 24 h (Fig. 1 C and E) and 72 h (Fig. 1 D and G). 269 
These results showed that differentiation of isolated cytotrophoblasts into a syncytiotrophoblast is 270 
associated with an increase in the expression and secretion of hCG and hPL, hormones mainly 271 
synthesized by the syncytiotrophoblast. 272 
 273 
Decrease in LH/CG-R protein levels during in vitro trophoblast differentiation 274 
As shown in figures 2 A and B, LH/CG-R was expressed by cultured cytotrophoblasts. The LH/CG-R 275 
immunostaining shown in this figure was obtained with the polyclonal antibody LHR-K15. Another 276 
antibody (LHR-H50) gave the same results (data not shown). LH/CG-R was expressed in both 277 
cytotrophoblasts (24 h) and syncytotrophoblasts (72 h), with punctuate immunolabeling. LH/CG-R 278 
immunostaining appeared stronger in cytotrophoblasts than in syncytiotrophoblasts. Double 279 
immunostaining for LH/CG-R (LHR-50) and hCG (C-20) of trophoblasts cultured for 48 hours (Fig. 2 280 
C and D respectively, merge Fig. 2 E) illustrated the dynamics of the process. A mononucleated 281 
cytotrophoblast (Fig. 2 C arrow head) expressed LH/CG-R, whereas aggregated trophoblasts showed 282 
and heterogenous immunostaining of both LH/CG-R and hCG (Fig. 2 E). To validate this observation, 283 
western-blot analysis was performed on extracts of cytotrophoblasts (24 h) and syncytiotrophoblasts 284 
(72 h) (Fig. 3 A). At 24 h and 72 h of culture, two major bands with molecular masses (estimated from 285 
SDS gels) of 65-75 kDa and 85-95 kDa were observed, as described in other cellular models and in 286 
mammalian cells transfected with LH/CG-R cDNA. In the literature, the 85-95 kDa band corresponds 287 
to the mature LH/CG-R present at the cell surface, and the 65-75 kDa band is the precursor of the cell-288 
surface receptor (for review see Ascoli et al., 2002).  289 
Our results show that the expression of the mature LH/CG-R and its precursor (respectively designated 290 
m and p in Fig. 3 A) decreases during cytotrophoblast differentiation. At the same time, actin 291 
expression remains constant. Normalization of mature LH/CG-R protein expression to actin 292 
expression showed a significant decrease (58.6 ± 6.7%; p< 0.0001) in cell-surface receptor expression. 293 
We obtained similar results with the two antibodies used (LHR-K15 and LHR-H50). 294 
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Interestingly, in the same cellular extracts, the decrease in precursor and mature LH/CG-R expression 295 
coincided with an increase in hCG and hPL expression (Fig. 3 A). 296 
To further characterize LH/CG-R expression during trophoblast differentiation, we performed 297 
immunoprecipitation (IP) with anti-human LH/CG-R antibody (K15). Cellular extracts were purified 298 
by immobilized anti-receptor antibody (IP) and eluates were analyzed by SDS-PAGE and 299 
immunoblotting using the receptor-specific antibody (K15). A 90 kDa band corresponded to the 300 
mature form of LH/CG-R (m), and a major band of 75 kDa corresponded to the precursor (p). 301 
To determine which molecular form of the receptor bound the hormone, we used 
125
I-hCG in ligand-302 
blot experiments (Fig. 3 B). Incubation of the IP blot with 
125
I-hCG (10
-11
M) revealed a major band of 303 
90 kDa. This band was absent when the blot was incubated with an excess of unlabeled hCG (10
-6 
M), 304 
showing that the 90-kDa LH/CG-R specifically binds the hormone. In these conditions, 
125
I- hCG 305 
binding to the mature form of the receptor (90 kDa) was lower in the syncytiotrophoblast than in 306 
cytotrophoblasts. 307 
 308 
Decrease in LH/CG-R mRNA expression during in vitro trophoblast differentiation 309 
We conducted semi-quantitative RT-PCR experiments with two different sets of primers (P1 and P2) 310 
(for primer positions see Fig. 4 A). To avoid contamination by genomic DNA, each primer was 311 
located on a separate exon and RNA extracts were pretreated with DNAse I.  312 
As shown in figure 4 B, amplification of the 647-bp and 282-bp fragments, obtained with primers P1 313 
and P2 respectively, indicated that LH/CG-R mRNA was significantly less abundant in the 314 
syncytiotrophoblast (72 h) than in cytotrophoblasts (24 h). No significant difference was noted in the 315 
actin mRNA level. We obtained similar results with the two sets of primers. The amplification 316 
products were then purified from the agarose gel and cloned into the pCRII-TOPO vector. Sequencing 317 
confirmed that both the 647-bp and 282-bp fragments were part of the human LH/CG receptor. 318 
Normalization of LH/CG-R mRNA to actin mRNA after RT-PCR with primer sets P1 and P2 showed 319 
a significant decrease in LH/CG-R mRNA levels during differentiation (Fig. 4 C). With the P1 320 
primers, LH/CG-R mRNA levels fell from 0.33 ± 0.01 at 24 h to 0.13 ± 0.01 at 72 h (p< 0.0001). A 321 
similar decrease was observed with the P2 primers (from 0.82 ± 0.02 at 24 h to 0.36 ± 0.01 at 72 h; p< 322 
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0.0001). Although the amplification product obtained with primers P2 appeared to be at least twice as 323 
abundant as that obtained with primers P1 (probably because the P2 amplicon is about half the length 324 
of the P1 amplicon), the size of the decrease in LH/CG-R levels at 72 h was similar with the two 325 
primer sets (respectively 2.5- and 2.3-fold). 326 
 327 
Decrease in 
125
I-hCG binding to cell-surface LH/CG-R during in vitro trophoblast differentiation 328 
To confirm the decrease in LH/CG-R mRNA and protein levels, we performed binding saturation 329 
experiments with iodinated hCG at 24 h and 72 h of culture (Fig. 5). Scatchard analysis of binding 330 
data showed that the number of molecules bound per seeded cell at 24 h of culture (cytotrophoblasts) 331 
was 3511±693. After differentiation, at 72 h of culture, this number fell significantly (p=0.02) to 332 
929±583. No significant difference in Kd values was observed between 24 h (0.5±0.1 nM) and 72 h 333 
(0.4±0.1 nM). 334 
 335 
LH/CG-R stimulation during in vitro trophoblast differentiation 336 
In order to confirm the reduction in functional mature hCG receptor expression at the 337 
syncytiotrophoblast surface compared to the cytotrophoblast surface, we determined cAMP production 338 
in response to an effective hCG concentration for 20 min (Fig. 6). As cAMP is a second messenger for 339 
hCG signaling in trophoblastic cells, the decrease in LH/CG-R transcript and protein levels ought to be 340 
associated with a decrease in cAMP production. Determination of the most effective hCG 341 
concentration was carried out by stimulating trophoblasts with 10
-12 
M to 10
-6 
M hCG; 10
-8 
M hCG was 342 
the most effective concentration (data not shown). As shown in figure 6, hCG-stimulated cAMP 343 
production by trophoblasts was higher at 24 h than at 72 h of culture (p= 0.0021). Trophoblast 344 
stimulation by hCG (10
-8 
M) at 24 h of culture induced at least a 2-fold increase in cAMP production 345 
compared to the basal level (p= 0.0016), but did not induce detectable cAMP production at 72 h of 346 
culture (p= 0.7644). In contrast, epinephrine (which stimulates camp production and is used as a 347 
positive control) induced similar cAMP production at 24 h and 72 h of culture, indicating that the cells 348 
were functional and that the decrease in cAMP production observed at 72 h was not due to a defective 349 
cAMP pathway. 350 
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Immunolocalization of LH/CG-R in villous sections 351 
These in vitro findings were confirmed by examining placental LH/CG-R expression in situ, on villous 352 
sections. First-trimester placenta was chosen because cytotrophoblasts are more abundant than at other 353 
stages of pregnancy and form a continuous layer. 354 
LH/CG-R was detected in villous cytotrophoblasts and syncytiotrophoblasts. Use of a polyclonal 355 
antibody raised against the extracellular domain of human LH/CG-R showed that LH/CG-R is mainly 356 
expressed by the cytotrophoblast layer (Fig. 7 A). Weaker staining was observed in the 357 
syncytiotrophoblast (ST). LH/CG-R was also expressed by perivascular cells (VC) of the villous core. 358 
We obtained similar results with two other monoclonal antibodies (LHR 29 and LHR 1055) which 359 
recognize two different epitopes of the extracellular domain of LH/CG-R (Vuhai et al., 1990; Méduri 360 
et al. 1997) (data not shown). No staining was detected in negative control sections  (Fig. 7 D). 361 
Interestingly, strong hCG immunostaining was observed in the syncytiotrophoblast (Fig. 7 B) while 362 
cytokeratin 7 was mainly located in the cytotrophoblast layer (Fig. 7 C). 363 
 364 
 Taken together, these results strongly suggest that the expression of a functional cell-surface 365 
LH/CG-R decreases during cytotrophoblast differentiation into a syncytiotrophoblast. 366 
 367 
 368 
DISCUSSION 369 
 370 
 By using several complementary methods and a well-characterized in vitro model of human 371 
villous trophoblast differentiation, we clearly observed that LH/CG-R mRNA and protein expression 372 
is lower in syncytiotrophoblasts than in cytotrophoblasts and that this down-regulation is associated 373 
with an apparent decrease of receptor activation by its specific hormone. These results differ from 374 
those of two previous studies published by CV. Rao, who described stronger expression of LH/CG-R 375 
in syncytiotrophoblasts than in cytotrophoblasts (Reshef et al., 1990; Lei and Rao, 1992). This 376 
divergence may come from the use of different tools. Anti-human LH/CG-R antibodies were not 377 
available in the early 1990s, and most immunohistochemical and western-blotting studies used 378 
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antibodies raised against the N-terminal part of the rat LH/CG receptor. The amino acid sequence 379 
identity between the rat and human receptors is 85%, with the strongest similitude in the 380 
transmembrane portion of the molecule and not in the N-terminal region (Segaloff and Ascoli, 1993). 381 
Moreover, experiments involving radiolabeled probes, such as northern blotting and in situ 382 
hybridization, used porcine cDNA with 88% sequence identity to the human sequence. In this study, 383 
we cloned PCR fragments of the human hCG/LH receptor from villous cytotrophoblasts and used 384 
antibodies specific for the human receptor. 385 
 HCG, which is produced in large amounts by the syncytiotrophoblast, plays an important role 386 
in cytotrophoblast differentiation into syncytiotrophoblast. An increasing number of studies have 387 
investigated the central role of hCG and its receptor in the trophoblastic differentiation process. Many 388 
authors have described down-regulation of LH/CG-R expression by increasing concentrations of hCG. 389 
Indeed, exposure of ovarian or testicular cells expressing the endogenous LH/CG-R to a high 390 
concentration of hCG down-regulates cell-surface receptor expression. This coincides with a decrease 391 
in the abundance of LH/CG-R transcripts (Segaloff et al., 1990; Peegel et al., 1994; Hoffman et al., 392 
1991; LaPolt et al., 1990; Hu et al., 1990). It is noteworthy in this respect that hCG is secreted in large 393 
amounts during syncytiotrophoblast formation. The decrease in cell-surface receptor expression was 394 
confirmed in our study by the clear decrease in cAMP production by the syncytiotrophoblast after 395 
stimulation by recombinant hCG. Interestingly, the decrease in cAMP production by the 396 
syncytiotrophoblast was not due to a loss of affinity or to weak binding between the receptor and its 397 
hormone, as we found no difference in LH/CG-R Kd values between 24 h and 72 h of culture. 398 
Moreover, Scatchard plots clearly showed that the maximum number of hCG molecules bound per 399 
seeded cell was significantly lower at 72 h of culture than at 24 h (~74%). This result confirms the 400 
decrease of LH/CG-R (~60%) observed by western-blot analysis. The difference in LH/CG-R decrease 401 
(60% versus 74%) may be due to the technical approaches used for the purpose. By western-blot 402 
analysis, we quantified the mature form of the LH/CG-R in proteins from total cellular extracts. In 403 
binding experiments, we used living cells, meaning that only the mature form of the LH/CG-R present 404 
at the cell surface was quantified. Some mature forms internalized or present in the endosome might 405 
not be accessible to 
125
I-hCG. 406 
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 LH/CG-R desensitization has been described in rat ovary and is accompanied by a transient 407 
loss of responsiveness to LH, the receptor being temporarily uncoupled from its Gs protein (Segaloff 408 
et al., 1990). We observed here that syncytiotrophoblast stimulation by recombinant hCG (10
-8 
M) did 409 
not induce detectable cAMP production although the cAMP pathway was functional as shown by 410 
epinephrine stimulation. This loss of responsiveness to recombinant hCG may thus be due in part to 411 
cell-surface receptor desensitization.  412 
 Western blotting showed that two major species of LH/CG-R with molecular masses of 65-75 413 
kDa and 85-95 kDa were expressed by cytotrophoblasts and by syncytiotrophoblasts. 414 
Immunoprecipitation experiments and ligand blot analysis confirmed that the 65-75 kDa band was the 415 
intracellular precursor of the cell-surface receptor and that the 85-95 kDa band corresponded to mature 416 
LH/CG-R present at the cell surface, as shown by its ability to bind specifically labeled 
125
I-hCG. Our 417 
results show that the expression of the mature LH/CG-R and its intracellular precursor decreased 418 
during cytotrophoblast differentiation. Furthermore, the precursor form seemed to be more strongly 419 
expressed than the mature form in trophoblastic cells. Most studies of these two forms of LH/CG-R 420 
have used mammalian cells transfected with the cDNA for the porcine, rat or human receptor (for 421 
review see Ascoli and al., 2002), but as shown here, primary cultured human trophoblasts may be an 422 
excellent model for studying the maturation of the intracellular precursor into the mature cell-surface 423 
protein. Recently, Pietila et al using transfection models have shown that regulation of the immature 424 
form into the mature form might considered be important in LH/CG-R expression (Pietila et al., 2005). 425 
 In this study, we characterized for the first time, in a human physiological model, the 426 
expression and regulation of LH/CG-receptor. We demonstrate, both in situ and in vitro, that LH/CG-427 
R is expressed by human cytotrophoblasts and, albeit to a lesser extent, by the syncytiotrophoblast. 428 
LH/CG-R expression thus seems to be regulated during villous trophoblast differentiation, and this 429 
regulation may involve down-regulation of the receptor by its ligand. Abnormal regulation of this 430 
process might be involved in trisomy 21-associated pregnancies, in which we recently observed an 431 
abnormal glycosylated form of hCG associated with defective syncytiotrophoblast formation (Frendo 432 
et al., 2000b, 2004). Abnormal syncytiotrophoblast formation might lead to complications such as 433 
preeclampsia and intrauterine growth retardation. 434 
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FIGURE LEGENDS 593 
 594 
Fig. 1 In vitro human villous trophoblast differentiation. (A) and (B): hCG immunodetection after 595 
24 and 72 hours of culture of villous cytotrophoblasts isolated from term placentas. At 24 hours the 596 
cells are sparse or aggregated (A). At 72 hours, they have fused to form the syncytiotrophoblast, 597 
characterized by multiple nuclei and a strong positive immunofluorescent staining for hCG (B). Nuclei 598 
were labeled with DAPI (blue fluorescence). (C) and (D): co-immunolocalization of cytokeratin 7 (in 599 
green) and hPL (in red) at 24 hours (C) and 72 hours of culture (D). Nuclei are stained blue with 600 
DAPI. HPL, known to be expressed mainly by the syncytiotrophoblast, was detected by 601 
immunostaining at 72 h (H) but not at 24 h of culture (F). Cytokeratin 7 immunostaining, was positive 602 
at 24 h (E) and 72 h (G). (I): levels of hCG and hPL (expressed respectively in milli-international 603 
units per milliliter and micrograms per milliliter of medium) secreted into the culture medium at the 604 
indicated times. Since cells were plated in triplicate (see Experimental procedures), hCG and hPL 605 
levels were determinated for each plate. ND: non detectable. Results are means ± SEM of the three 606 
culture dishes. This figure illustrates one experiment representative of three. Scale for pictures A-D: 1 607 
cm = 30 µm. Scale for pictures E-H: 0.5 cm = 30 µm. 608 
 609 
Fig. 2 LH/CG-R immunodetection during in vitro trophoblast differentiation. (A) and (B): 610 
immunostaining for LH/CG-R by using the polyclonal antibody LHR-K15 raised against the human 611 
LH/CG receptor. LH/CG-R was expressed in both cyto- (A; 24h) and syncytotrophoblasts (B; 72h), 612 
albeit more strongly in cytotrophoblasts. (E): co-immunodetection of LH/CG-R and hCG by using the 613 
polyclonal antibodies LHR-H50 (C; in green) and hCG-C20 (D; in red) respectively at 48 hours of 614 
culture. Single trophoblast (arrowed) was stained for LH/CG-R and aggregated trophoblasts were 615 
stained for both LH/CG-R and hCG. Nuclei were labeled with DAPI (blue fluorescence). Scale for 616 
pictures A and B: 0.5 cm = 30 µm; scale for pictures C-E: 1 cm = 15 µm. 617 
 618 
Fig. 3 LH/CG-R protein expression during in vitro trophoblast differentiation. (A) and (B): 619 
Western-blot analyses (A) were performed using the same antibody on extracts from cytotrophoblasts 620 
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(24 h) and syncytiotrophoblasts (72 h). At 24 h and 72 h of culture, two major bands with molecular 621 
masses of 65-75 kDa, corresponding to the precursor (p) of the cell-surface receptor and 85-95 kDa, 622 
corresponding to the mature LH/CG-R (m) present at the cell surface, were observed. The histogram 623 
presents the normalization of mature LH/CG-R protein expression (m) by actin expression (43kDa) 624 
(***: p< 0.0001). Results are expressed as the mean ± SEM of three culture dishes. In the same 625 
cellular extracts, decrease in precursor and mature LH/CG-R expression was concomitant with an 626 
increase in hCG (38kDa) and hPL (22 kDa) expression. (B): immuno-precipitation and ligand-blot 627 
analysis. Cellular extracts were purified by immobilized anti-receptor antibody. Eluates were analyzed 628 
by SDS-PAGE and immunoblotting using the receptor-specific antibody. A 90 kDa band 629 
corresponding to the mature form of LH/CG-R (m) and a major band with a molecular mass of 75 kDa 630 
corresponding to the precursor (p) were observed. Incubation of the IP blot with labeled 
125
I-hCG (10
-631 
11
M) revealed a major radioactive band at a molecular weight of 90 kDa, which was not detected when 632 
the blot was incubated with an excess of unlabeled hCG (10
-6 
M). Figures A and B illustrate one 633 
experiment representative of five. 634 
 635 
Fig. 4 LH/CG-R mRNA expression during in vitro trophoblast differentiation. (A): diagram 636 
showing the seven transmembrane domains of the LH/CG-receptor and the location of the primers sets 637 
used in this study. The two sets of primers (P1 and P2) are located on the extracellular domain. P1 638 
amplifies a fragment of 647-bp in the exons 2-9 and P2 amplifies a fragment of 282-bp in the exons 1-639 
5. (B): Ethidium bromide-staining gel of one representative of five independent experiments. Semi-640 
quantitative RT-PCR experiments with both the primers P1 and P2 shows respectively a 647-bp and a 641 
282-bp amplified fragment. RT-PCR products were separated on 1.8% agarose gel and analysed by 642 
densitometry. Sequencing confirmed that both the 647-bp and the 282-bp fragments are part of the 643 
LH/CG receptor. (C): histograms represent the normalization of LH/CG-R mRNA by actin mRNA 644 
after RT-PCR with primers sets P1 (upper histogram) and P2 (lower histogram). Data are expressed as 645 
mean ± SEM of five independent experiments similar to the one shown in B. bp: base pairs; ***: p< 646 
0.0001. 647 
 648 
 26 
Fig. 5 Scatchard analyses of 
125
I-hCG binding to trophoblasts during in vitro differentiation. 649 
Binding was performed for 30 minutes at room temperature, on cells at 24 hours () or 72 hours () 650 
of culture. The apparent dissociation constants (Kd) and the maximum number of molecules bound per 651 
mg of protein at 24 hours and 72 hours of culture were calculated by the LIGAND program (lower 652 
table). Results are expressed as the mean ± SEM of three experiments. 653 
 654 
Fig. 6 Intracellular cAMP production after LH/CG-R stimulation during in vitro trophoblasts 655 
differentiation. Stimulation of cells at 24 hours and 72 hours of culture was performed with 10
-8
 M of 656 
hCG or with epinephrine (used as a positive control) for 20 min and compared to non stimulated cells 657 
(0). **: p< 0.005 and ***: p< 0.0001 658 
 659 
Fig. 7 Immunolocalization of LH/CG-R, hCG and cytokeratin 7 in villous sections. (A): 660 
immunohistochemical staining of LH/CG-R, using the polyclonal antibody (H50) raised against the 661 
extracellular domain. Villous cytotrophoblasts (CT), syncytiotrophoblast (ST) and perivascular cells 662 
(VC) of the villous core were positively stained. (B): a strong immunostaining of hCG was observed 663 
in the syncytiotrophoblast. (C): immunostaining of cytokeratin 7 was mainly located in 664 
cytotrophoblasts layer. (D): No staining was observed in control sections treated with non specific 665 
isotypic immunoglobulins. 666 
